Ortho Clinical Diagnostics Holdings plc (OCDX): Price and Financial Metrics

Ortho Clinical Diagnostics Holdings plc (OCDX): $17.63

0.08 (+0.46%)

POWR Rating

Component Grades








Add OCDX to Watchlist
Sign Up

Industry: Medical - Services




#7 of 87

in industry

OCDX Price/Volume Stats

Current price $17.63 52-week high $22.99
Prev. close $17.55 52-week low $16.04
Day low $17.47 Volume 5,847,500
Day high $17.79 Avg. volume 1,240,588
50-day MA $18.11 Dividend yield N/A
200-day MA $18.78 Market Cap 3.92B

OCDX Stock Price Chart Interactive Chart >

Ortho Clinical Diagnostics Holdings plc (OCDX) Company Bio

Ortho Clinical Diagnostics Holdings plc operates as a holding company. The Company, through its subsidiaries, provides vitro diagnostics products and services to the global clinical laboratory and immunohematology communities. Ortho Clinical Diagnostics Holdings serves customers worldwide.

OCDX Latest News Stream

Event/Time News Detail
Loading, please wait...

OCDX Latest Social Stream

Loading social stream, please wait...

View Full OCDX Social Stream

Latest OCDX News From Around the Web

Below are the latest news stories about Ortho Clinical Diagnostics Holdings plc that investors may wish to consider to help them evaluate OCDX as an investment opportunity.

Will Ortho Clinical (OCDX) Gain on Rising Earnings Estimates?

Ortho Clinical (OCDX) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.

Yahoo | February 25, 2022

OCDX vs. DOCS: Which Stock Is the Better Value Option?

OCDX vs. DOCS: Which Stock Is the Better Value Option?

Yahoo | February 25, 2022

Wall Street Analysts See a 54% Upside in Ortho Clinical (OCDX): Can the Stock Really Move This High?

The consensus price target hints at a 54.3% upside potential for Ortho Clinical (OCDX). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.

Yahoo | February 23, 2022

Best Value Stocks to Buy for February 18th

CIVI, DBI, and OCDX made it to the Zacks Rank #1 (Strong Buy) value stocks list on February 18, 2022

Yahoo | February 18, 2022

H.C. Wainwright Reiterates a Hold Rating on Ortho Clinical Diagnostics Holdings (OCDX)

In a report released today, Yi Chen from H.C. Wainwright reiterated a Hold rating on Ortho Clinical Diagnostics Holdings (OCDX – Research Report), with a price target of $24.68. The company's shares closed last Wednesday at $16.32, close to its 52-week low of $15.53. According to TipRanks.com, Chen is a 4-star analyst with an average return of 14.7% and a 37.7% success rate. Chen covers the Healthcare sector, focusing on stocks such as HTG Molecular Diagnostics, EyePoint Pharmaceuticals, and Stealth Biotherapeutics. Currently, the analyst consensus on Ortho Clinical Diagnostics Holdings is a Moderate Buy with an average price target of $23.56.

Brian Anderson on TipRanks | February 17, 2022

Read More 'OCDX' Stories Here

OCDX Price Returns

1-mo N/A
3-mo N/A
6-mo N/A
1-year N/A
3-year -18.46%
5-year N/A
2023 N/A
2022 0.00%
2021 N/A
2020 N/A
2019 N/A

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!